APA (7th ed.) Citation

Y, O., YT, N., WW, H., & N, G. (2026). Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore. Therapeutic advances in medical oncology, 18, 17588359261421557. https://doi.org/10.1177/17588359261421557

Chicago Style (17th ed.) Citation

Y, Ouyang, Ng YT, Hong WW, and Graves N. "Updated Cost Comparison of Home Care Subcutaneous Versus Outpatient Intravenous Trastuzumab for HER2-positive Breast Cancer in Singapore." Therapeutic Advances in Medical Oncology 18 (2026): 17588359261421557. https://doi.org/10.1177/17588359261421557.

MLA (9th ed.) Citation

Y, Ouyang, et al. "Updated Cost Comparison of Home Care Subcutaneous Versus Outpatient Intravenous Trastuzumab for HER2-positive Breast Cancer in Singapore." Therapeutic Advances in Medical Oncology, vol. 18, 2026, p. 17588359261421557, https://doi.org/10.1177/17588359261421557.